Aaron Arnold

728 total citations
40 papers, 456 citations indexed

About

Aaron Arnold is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Aaron Arnold has authored 40 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Surgery. Recurrent topics in Aaron Arnold's work include Hormonal and reproductive studies (7 papers), Estrogen and related hormone effects (5 papers) and Cholesterol and Lipid Metabolism (4 papers). Aaron Arnold is often cited by papers focused on Hormonal and reproductive studies (7 papers), Estrogen and related hormone effects (5 papers) and Cholesterol and Lipid Metabolism (4 papers). Aaron Arnold collaborates with scholars based in United States, United Kingdom and Vietnam. Aaron Arnold's co-authors include A. L. Beyler, G. O. Potts, J.P. McAuliff, A. J. Manson, F. W. Stonner, Aristide Merola, R. O. Clinton, S. A. Archer, F. J. Twarog and Anahita F. Dioun and has published in prestigious journals such as Science, Journal of the American Chemical Society and American Journal of Clinical Nutrition.

In The Last Decade

Aaron Arnold

38 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aaron Arnold United States 12 155 104 90 53 51 40 456
Thomas R. Blohm United States 12 235 1.5× 140 1.3× 48 0.5× 41 0.8× 24 0.5× 28 484
A. L. Beyler United States 14 207 1.3× 162 1.6× 165 1.8× 34 0.6× 29 0.6× 33 629
Naoyuki Koizumi Japan 15 232 1.5× 96 0.9× 129 1.4× 23 0.4× 32 0.6× 21 590
A Radomińska-Pyrek United States 14 311 2.0× 46 0.4× 35 0.4× 23 0.4× 39 0.8× 23 559
Laurie L. McLeod United States 8 240 1.5× 55 0.5× 60 0.7× 19 0.4× 71 1.4× 8 511
Dwight D. Stiff United States 13 158 1.0× 51 0.5× 31 0.3× 51 1.0× 18 0.4× 18 444
Winston Ho United States 11 263 1.7× 44 0.4× 127 1.4× 12 0.2× 127 2.5× 20 509
Stanley C. Lyster United States 14 123 0.8× 85 0.8× 85 0.9× 59 1.1× 17 0.3× 30 481
Dyral C. Fessler United States 7 383 2.5× 70 0.7× 134 1.5× 51 1.0× 32 0.6× 10 657
Karl Romstedt United States 12 202 1.3× 17 0.2× 113 1.3× 120 2.3× 68 1.3× 34 462

Countries citing papers authored by Aaron Arnold

Since Specialization
Citations

This map shows the geographic impact of Aaron Arnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron Arnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron Arnold more than expected).

Fields of papers citing papers by Aaron Arnold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron Arnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron Arnold. The network helps show where Aaron Arnold may publish in the future.

Co-authorship network of co-authors of Aaron Arnold

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron Arnold. A scholar is included among the top collaborators of Aaron Arnold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron Arnold. Aaron Arnold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jacobs, Leah A., et al.. (2024). There goes the neighborhood? The public safety enhancing effects of a mobile harm reduction intervention. International Journal of Drug Policy. 124. 104329–104329. 4 indexed citations
2.
Arnold, Aaron. (2019). Being alert: bridging theory and practice in public sector entrepreneurship. International Journal of Public Sector Management. 32(7). 706–720. 13 indexed citations
3.
Turvey, Stuart E., et al.. (2004). Adverse reactions to vitamin B12 injections due to benzyl alcohol sensitivity: successful treatment with intranasal cyanocobalamin. Allergy. 59(9). 1023–1024. 26 indexed citations
4.
Heyneman, Catherine A, et al.. (2002). Fluticasone Versus Salmeterol/Low-Dose Fluticasone for Long-Term Asthma Control. Annals of Pharmacotherapy. 36. 1944–1949.
5.
Arnold, Aaron, J.P. McAuliff, & A. L. Beyler. (1979). Metabolic Effects of a New Hypolipidemic Agent, Ciprofibrate. Journal of Pharmaceutical Sciences. 68(12). 1557–1558. 12 indexed citations
6.
Bailey, Denis M., David K. Wood, E. R. Johnson, et al.. (1972). Lowering of serum lipid levels by "masked" nicotinic acid derivatives. Journal of Medicinal Chemistry. 15(4). 344–348. 9 indexed citations
7.
Arnold, Aaron & J.P. McAuliff. (1969). Relative blocking effectiveness of propranolol and of practalol [4-(2-hydroxy-3-isopropylaminopropoxy) acetanilide] on isoprenaline in β-1 receptor mediated calorigenesis. Journal of Pharmacy and Pharmacology. 21(9). 624–625. 1 indexed citations
8.
Beyler, A. L., Aaron Arnold, & G. O. Potts. (1968). Methods for evaluating anabolic and catabolic agents in laboratory animals.. PubMed. 23(8). 708–12. 1 indexed citations
9.
Arnold, Aaron & J.P. McAuliff. (1968). Guinea-pig adipose tissue responsiveness to catecholamines. Cellular and Molecular Life Sciences. 24(5). 436–436. 7 indexed citations
10.
Arnold, Aaron & J.P. McAuliff. (1968). Relative lipolytic activities in vitro of a series of phenethyl amines. Biochemical Pharmacology. 17(3). 475–477. 5 indexed citations
11.
Tainter, M. L., et al.. (1964). ANABOLIC STEROIDS IN THE MANAGEMENT OF THE DIABETIC PATIENT.. PubMed. 64. 1001–9. 7 indexed citations
12.
Arnold, Aaron, G. O. Potts, & A. L. Beyler. (1963). Evaluation of the Protein Anabolic Properties of Certain Orally Active Anabolic Agents Based on Nitrogen Balance Studies in Rats1. Endocrinology. 72(3). 408–417. 16 indexed citations
13.
Arnold, Aaron, G. O. Potts, & A. L. Beyler. (1963). RELATIVE ORAL ANABOLIC TO ANDROGENIC ACTIVITY RATIOS OF ANDROISOXAZOLE, ETHYLESTRENOL, METHYLANDROSTENOLISOXAZOLE AND TESTOSTERONE. European Journal of Endocrinology. 44(4). 490–498. 9 indexed citations
14.
Arnold, Aaron, et al.. (1962). Maintenance of Elevated Blood Levels of Vitamin B 12 in Human Subjects. American Journal of Clinical Nutrition. 10(1). 56–58. 5 indexed citations
15.
Archer, S. A., et al.. (1960). AUGMENTATION OF PHARMACOLOGICAL PROPERTIES OF CATECHOLAMINES BY O-METHYL TRANSFERASE INHIBITORS. Journal of Pharmacology and Experimental Therapeutics. 130(3). 239–244. 37 indexed citations
16.
Arnold, Aaron, A. L. Beyler, & G. O. Potts. (1959). Andro-stanazole, A New Orally Active Anabolic Steroid. Experimental Biology and Medicine. 102(1). 184–187. 16 indexed citations
17.
Arnold, Aaron, et al.. (1956). Inhibition Studies with Streptococcus faecalis. Acridines and Acridones. Experimental Biology and Medicine. 91(2). 282–285. 1 indexed citations
18.
Lands, A.M., et al.. (1955). AN EVALUATION OF THE PHARMACOLOGIC ACTIONS OF SOME BIS-QUATERNARY SALTS OF BASICALLY SUBSTITUTED OXAMIDES (WIN 8077 AND ANALOGS). Journal of Pharmacology and Experimental Therapeutics. 115(2). 185–198. 10 indexed citations
19.
Arnold, Aaron, et al.. (1951). THE IN VIVO PROTEOLYTIC ACTIVITY OF PAPAIN AS DEMONSTRATED BY NITROGEN BALANCE STUDIES IN DOGS. Annals of the New York Academy of Sciences. 54(2). 282–296. 2 indexed citations
20.
Arnold, Aaron, et al.. (1951). DEMONSTRATION OF THE IN VIVO ACTIVITY OF PAPAIN. Annals of the New York Academy of Sciences. 54(2). 273–276. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026